Cargando…
Durable Response to Pazopanib in Recurrent Metastatic Carotid Body Paraganglioma
We present the case of a 26-year-old woman living at a high altitude diagnosed initially with nonfamilial and nonsecretory localized carotid body tumor managed with surgery, which developed into a recurrent metastatic tumor treated with cyclophosphamide, vincristine, and dacarbazine. The patient con...
Autores principales: | Alshamsan, Bader, Atallah, Jean Paul |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
S. Karger AG
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7590747/ https://www.ncbi.nlm.nih.gov/pubmed/33173489 http://dx.doi.org/10.1159/000510003 |
Ejemplares similares
-
Durable Major Response With Pazopanib in Recurrent, Heavily Pretreated Metastatic Esthesioneuroblastoma Harboring a Fumarate Hydratase Mutation
por: Spengler, Marianne, et al.
Publicado: (2021) -
Huge carotid body paraganglioma
por: Park, Sang Jun, et al.
Publicado: (2011) -
Real-World Outcome and Prognostic Factors of Pazopanib in Advanced Soft Tissue Sarcoma
por: Alshamsan, Bader, et al.
Publicado: (2021) -
Successful Response to Cyclophosphamide, Vincristine, and Dacarbazine Chemotherapy in a Patient with Metastatic Carotid Body Paraganglioma
por: Yamada, Hiroki, et al.
Publicado: (2021) -
Carotid Body Paraganglioma
por: Hosalkar, Rashmi Maruti, et al.
Publicado: (2019)